Answers are grounded in this paper and cite their sources.
This Viewpoint argues that the development of a distinctly improved generation of SARS-CoV-2 vaccines is paramount to offering a greater breadth and depth of protection for a longer duration against COVID-19 disease.
No takes yet. Share an insight, caveat, or question.
Marks et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: